Donald J Hayden Jr's Net Worth

$27.3 Million

Estimate Recalculated Nov 8, 2024 04:35PM EST

Who is Donald J Hayden Jr?

Donald J Hayden Jr has an estimated net worth of $27.3 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, REGENXBIO Inc., AMICUS THERAPEUTICS INC, INSMED Inc, Theseus Pharmaceuticals, Inc., and Vitae Pharmaceuticals, Inc.

SEC CIK

Donald J Hayden Jr's CIK is 0001202285

Past Insider Trading and Trends

2017 was Donald J Hayden Jr's most active year for acquiring shares with 14 total transactions. Donald J Hayden Jr's most active month to acquire stocks was the month of May. 2017 was Donald J Hayden Jr's most active year for disposing of shares, totalling 24 transactions. Donald J Hayden Jr's most active month to dispose stocks was the month of August. 2015 saw Donald J Hayden Jr paying a total of $950,687.50 for 196,664 shares, this is the most they've acquired in one year. In 2020 Donald J Hayden Jr cashed out on 120,000 shares for a total of $2,870,760.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6

EVP and President, Americas

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.73%
16.67K
—
—
207.65K
Mar 1
Form 4
-2.64%
-5.17K
$23.64
-$122,313.36
190.98K
Dec 1
Form 4
+10.31%
18.33K
—
—
196.16K
Mar 2
Form 4
-2.80%
-5.13K
$26.63
-$136,532.01
177.82K
Dec 1
Form 4
+37.61%
50K
—
—
182.95K
Sep 10
No matching records found

REGENXBIO Inc. (RGNX) Snapshot price: $11.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 29
Form 4
—
0
$25.48
-$1,221,648.00
0
Scheduled
Feb 10
Form 4
—
0
$25.43
-$98,300.00
0
Scheduled
Feb 5
Form 4
—
0
$25.43
-$157,312.00
0
Scheduled
Jan 17
Form 4
—
0
$23.23
-$1,342,500.00
0
Scheduled
Jan 14
Form 4
—
0
—
—
0
May 31
Form 4
—
0
$27.93
-$812,399.00
0
Scheduled
Jun 1 - Jun 5
Form 4
—
0
—
—
0
May 25
Form 4
—
0
$25.45
-$738,046.94
0
Scheduled
May 14 - May 15
Form 4
—
0
$22.93
-$662,250.00
0
Scheduled
May 9
Form 4
—
0
$17.90
-$682,000.00
0
Scheduled
Oct 11
Form 4
—
0
$16.65
-$632,000.00
0
Scheduled
Sep 27
Form 4
—
0
$14.78
-$1,114,000.00
0
Scheduled
Sep 15 - Sep 18
Form 4
—
0
$12.90
-$482,000.00
0
Scheduled
Sep 5
Form 4
—
0
—
—
0
May 24
Form 4
-100.00%
-8.60K
$19.04
-$163,724.96
0
Scheduled
May 15
Form 4
-53.77%
-10.00K
$18.35
-$183,500.00
8.6K
Scheduled
May 8
Form 4
-34.97%
-10.00K
$11.56
-$650,735.58
18.6K
Scheduled
May 1
Form 4
-25.91%
-10.00K
$20.98
-$209,800.00
28.6K
Scheduled
Apr 24
Form 4
—
0
—
—
0
Jun 1
Form 4/A
—
0
—
—
0
Sep 16
Form 4
∞
38.6K
—
—
38.6K
Sep 22
Form 4
—
0
—
—
0
Sep 16
Form 3
—
0
—
—
0
No matching records found

AMICUS THERAPEUTICS INC (FOLD) Snapshot price: $11.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+52.99%
3.08K
—
—
8.89K
Jun 7
Form 4
—
0
$15.00
—
5.81K
Scheduled
Jan 2
Form 4
∞
5.81K
—
—
5.81K
Jun 13
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
$14.01
—
0
Scheduled
Jun 23
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 10
Form 3
—
0
—
—
0
No matching records found

INSMED Inc (INSM) Snapshot price: $71.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$18.01
-$188,328.56
62.2K
Scheduled
Apr 9
Form 4
—
0
$15.47
-$2,487.00
62.2K
Scheduled
Feb 15
Form 4
—
0
$15.56
-$373,245.00
62.2K
Scheduled
Feb 22
Form 4
+10.81%
6.07K
—
—
62.2K
May 15
Form 4
—
0
$17.77
-$442,050.00
56.13K
Scheduled
Nov 14
Form 4
—
0
$16.35
-$1,198,650.00
56.13K
Scheduled
Sep 5 - Sep 7
Form 4
+13.56%
6.7K
—
—
56.13K
May 17
Form 4
+34.73%
12.74K
—
—
49.43K
May 19
Form 4
-40.53%
-25.00K
$24.06
-$601,443.50
36.69K
Sep 1 - Sep 2
Form 4
+11.22%
6.22K
—
—
61.69K
Jan 8
Form 4
+27.27%
11.88K
—
—
55.47K
Jan 10 - Jan 11
Form 4
+57.94%
15.99K
—
—
43.58K
Jan 11 - Jan 14
Form 4
+45.23%
8.59K
—
—
27.59K
Jan 23
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Dec 21
Form 4/A
+763.64%
16.8K
$5.28
$88,760.00
19K
Mar 24 - Mar 25
Form 4
+20.49%
2.2K
$6.36
$13,992.00
12.94K
Mar 29
Form 4
∞
10.74K
$5.18
$55,656.54
10.74K
Mar 24 - Mar 25
Form 4
—
0
—
—
0
Jan 12
Form 3
—
0
—
—
0
No matching records found

Theseus Pharmaceuticals, Inc. (THRX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-10.00K
—
—
0
Feb 14
Form 4
—
0
—
—
0
Jun 13
Form 4
∞
10K
$5.00
$49,989.11
10K
Dec 29 - Dec 30
Form 4
—
0
—
—
0
May 17
Form 3
—
0
—
—
0
No matching records found